Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.
Show original
Bitget offers a variety of ways to buy or sell popular cryptocurrencies.Buy now!
A welcome pack worth 6200 USDT for new users!Sign up now!
Meanwhile, the institution has set a target stock price of $330. This rating contrasts with the previous "buy" rating given by the institution, and the target price has also been significantly lowered from the previous high of $522 to $330. This adjustment reflects analysts' reassessment of the company's future prospects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Analysts predict bitcoin may stabilize at $74,000, while ETH is expected to reach $2,400
AIcoin•2026/03/16 09:30
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$73,258.4
+1.98%
Ethereum
ETH
$2,255.12
+6.48%
Tether USDt
USDT
$1
+0.00%
BNB
BNB
$676.1
+1.71%
XRP
XRP
$1.47
+3.70%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$93.11
+5.01%
TRON
TRX
$0.2969
-0.13%
Dogecoin
DOGE
$0.1008
+4.57%
Cardano
ADA
$0.2865
+7.86%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now